BioXcel Therapeutics Inc. (BTAI) Gained 7.39% or 0.68 To Price $9.88 On Tuesday


BioXcel Therapeutics Inc. (BTAI) gained 7.39% or 0.68 to $9.88. It is near 31542 shares traded, which is 93.12% compare to the average total volume 33871. The market cap of BTAI is $154.58 million. The year to date change is -9.2%. The 52 week price range is from $6.76 to $14.79. Price of BTAI have changed 8.88% during last week. It have changed -3.06% over last month, -18.29% over last 3 months, -16.59% over last 6 months and -16.59% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BTAI is 9.62. It is -2.63% below current price. The 52-week High is 14.79. It is 49.70% from the current price. The 52-week Low is 6.76. It is -31.58% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BTAI is 1.04 on 2018-08-15. Short % to float is 0.22%. There are some statistics of BTAI. It is has market cap $154.58 million. The share outstanding is 15.65 million. The average volume is 33871. The percent of top 15 Institution holding is 29.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BTAI is -21.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BTAI is -21.00%.


Tags:

Share this post